title: Androgen levels in women using a single implant of nomegestrol acetate.
abstract: This study was undertaken to evaluate the effects of a single implant containing nomegestrol acetate (Uniplant) on plasma levels of sex hormone-binding globulin (SHBG), testosterone, free testosterone, androstenedione and on blood pressure, body weight, and the development of acne vulgaris. Plasma levels of sex hormone-binding globulin, testosterone, free testosterone and androstenedione were measured. Blood pressure and body weight were determined. The development of acne vulgaris was evaluated. Total testosterone and androstenedione decreased significantly during two years of Uniplant use but all levels were within the normal range. There were no significant differences in sex hormone-binding globulin and free testosterone during 24 months of Uniplant use. All changes observed in this study were within normal range. SHBG was not affected by Uniplant use. No significant increase in androgen levels and in the development of acne vulgaris was observed in these women using nomegestrol acetate implant during two years. Based on these results, it is possible to conclude that Uniplant had no androgenic effect in women during this study.
authors.affiliation: Materinidade Climerio de Oliveira, Federal University of Bahia, Brazil.
authors.forename: I
authors.initials: I
authors.lastname: Barbosa
authors.forename: E
authors.initials: E
authors.lastname: Coutinho
authors.forename: C
authors.initials: C
authors.lastname: Athayde
authors.forename: O A
authors.initials: OA
authors.lastname: Ladipo
authors.forename: S E
authors.initials: SE
authors.lastname: Olsson
authors.forename: U
authors.initials: U
authors.lastname: Ulmsten
mesh_terms: D000152:Acne Vulgaris / Q000139:chemically induced / Q000453:epidemiology; D000328:Adult; D000728:Androgens / Q000097:blood*; D000735:Androstenedione / Q000097:blood; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D001835:Body Weight / Q000187:drug effects / Q000502:physiology; D001938:Brazil / Q000453:epidemiology; D004343:Drug Implants; D005260:Female; D006801:Humans; D015994:Incidence; D008535:Megestrol; D009649:Norpregnadienes / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D012738:Sex Hormone-Binding Globulin / Q000032:analysis; D013739:Testosterone / Q000097:blood
chemical_list: D000728:Androgens; D004343:Drug Implants; D009649:Norpregnadienes; D045167:Progesterone Congeners; D012738:Sex Hormone-Binding Globulin; D013739:Testosterone; D000735:Androstenedione; C038501:nomegestrol acetate; D008535:Megestrol